Hydroxychloroquine for the treatment of severe respiratory infection by COVID-19: A randomized controlled trial

Carmen Hernandez-Cardenas; Ireri Thirion-Romero; Sebastián Rodríguez-Llamazares; Norma E. Rivera-Martinez; Patricia Meza-Meneses; Arantxa Remigio-Luna; Rogelio Perez-Padilla; on behalf of the Research Group on hydroxychloroquine for COVID-19

doi:10.1371/journal.pone.0257238

Loading metrics

Open Access

Peer-reviewed

Research Article

Hydroxychloroquine for the treatment of severe respiratory infection by COVID-19: A randomized controlled trial

Carmen Hernandez-Cardenas,

Roles Conceptualization, Formal analysis, Investigation, Methodology, Supervision, Writing – original draft

Affiliation Instituto Nacional de Enfermedades Respiratorias, Mexico City, México
⨯
Ireri Thirion-Romero,

Roles Conceptualization, Formal analysis, Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing

Affiliation Instituto Nacional de Enfermedades Respiratorias, Mexico City, México

https://orcid.org/0000-0002-9038-2588

⨯
Sebastián Rodríguez-Llamazares,

Roles Conceptualization, Methodology, Writing – review & editing

Affiliation Instituto Nacional de Enfermedades Respiratorias, Mexico City, México

https://orcid.org/0000-0002-7864-8953

⨯
Norma E. Rivera-Martinez,

Roles Data curation, Formal analysis, Investigation, Methodology, Resources, Supervision, Validation

Affiliation Hospital Regional de Alta Especialidad Oaxaca, Oaxaca, México

https://orcid.org/0000-0002-6716-1234

⨯
Patricia Meza-Meneses,

Roles Data curation, Investigation, Methodology, Supervision, Validation, Writing – original draft

Affiliation Hospital Regional de Alta Especialidad Ixtapaluca, Estado de México, México

https://orcid.org/0000-0002-3931-3114

⨯
Arantxa Remigio-Luna,

Roles Conceptualization, Data curation, Investigation, Supervision, Validation, Visualization

Affiliation Instituto Nacional de Enfermedades Respiratorias, Mexico City, México
⨯
Rogelio Perez-Padilla ,

Roles Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

* E-mail: perezpad@gmail.com

Affiliation Instituto Nacional de Enfermedades Respiratorias, Mexico City, México

https://orcid.org/0000-0002-1132-5308

⨯
on behalf of the Research Group on hydroxychloroquine for COVID-19

¶The complete membership of the author group can be found in the Acknowledments.
⨯

Hydroxychloroquine for the treatment of severe respiratory infection by COVID-19: A randomized controlled trial

Carmen Hernandez-Cardenas,
Ireri Thirion-Romero,
Sebastián Rodríguez-Llamazares,
Norma E. Rivera-Martinez,
Patricia Meza-Meneses,
Arantxa Remigio-Luna,
Rogelio Perez-Padilla,
on behalf of the Research Group on hydroxychloroquine for COVID-19

Published: September 28, 2021
https://doi.org/10.1371/journal.pone.0257238

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

COVID 19
Is the Subject Area "COVID 19" applicable to this article?

Thanks for your feedback.
Nosocomial infections
Is the Subject Area "Nosocomial infections" applicable to this article?

Thanks for your feedback.
Respiratory infections
Is the Subject Area "Respiratory infections" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Oxygen
Is the Subject Area "Oxygen" applicable to this article?

Thanks for your feedback.
Reverse transcriptase-polymerase chain reaction
Is the Subject Area "Reverse transcriptase-polymerase chain reaction" applicable to this article?

Thanks for your feedback.
Virus testing
Is the Subject Area "Virus testing" applicable to this article?

Thanks for your feedback.
Death rates
Is the Subject Area "Death rates" applicable to this article?

Thanks for your feedback.